DK1948176T3 - Diarylurinstoffer til behandling af pulmonær hypertension - Google Patents

Diarylurinstoffer til behandling af pulmonær hypertension

Info

Publication number
DK1948176T3
DK1948176T3 DK06828882.8T DK06828882T DK1948176T3 DK 1948176 T3 DK1948176 T3 DK 1948176T3 DK 06828882 T DK06828882 T DK 06828882T DK 1948176 T3 DK1948176 T3 DK 1948176T3
Authority
DK
Denmark
Prior art keywords
diarylurines
treatment
pulmonary hypertension
hypertension
pulmonary
Prior art date
Application number
DK06828882.8T
Other languages
English (en)
Inventor
Peter Sandner
Hanna Tinel
Joachim Huetter
Bernd Riedl
Ralph Schermuly
Friedrich Grimminger
Martina Klein
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1948176T3 publication Critical patent/DK1948176T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK06828882.8T 2005-11-10 2006-10-30 Diarylurinstoffer til behandling af pulmonær hypertension DK1948176T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05024508 2005-11-10
EP05027449 2005-12-15
EP06007775 2006-04-13
PCT/EP2006/010405 WO2007054215A1 (en) 2005-11-10 2006-10-30 Diaryl ureas for treating pulmonary hypertension

Publications (1)

Publication Number Publication Date
DK1948176T3 true DK1948176T3 (da) 2011-04-18

Family

ID=37651281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06828882.8T DK1948176T3 (da) 2005-11-10 2006-10-30 Diarylurinstoffer til behandling af pulmonær hypertension

Country Status (23)

Country Link
US (1) US20090176791A1 (da)
EP (1) EP1948176B1 (da)
JP (1) JP5075832B2 (da)
KR (1) KR20080066030A (da)
AR (1) AR057848A1 (da)
AT (1) ATE493986T1 (da)
AU (1) AU2006312713A1 (da)
BR (1) BRPI0618524A2 (da)
CA (1) CA2628847A1 (da)
CU (1) CU23815A3 (da)
DE (1) DE602006019468D1 (da)
DK (1) DK1948176T3 (da)
EC (1) ECSP088429A (da)
IL (1) IL191010A0 (da)
MY (1) MY144860A (da)
NO (1) NO20082497L (da)
NZ (1) NZ568031A (da)
PL (1) PL1948176T3 (da)
PT (1) PT1948176E (da)
SV (1) SV2009002899A (da)
TW (1) TW200735869A (da)
UY (1) UY29902A1 (da)
WO (1) WO2007054215A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
CA2526617C (en) 2003-05-20 2015-04-28 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
UA84156C2 (ru) 2003-07-23 2008-09-25 Байер Фармасьютикалс Корпорейшн Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
SG160364A1 (en) 2005-03-07 2010-04-29 Bayer Schering Pharma Ag Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
US20090197922A1 (en) * 2006-01-24 2009-08-06 The University Of Chicago Compositions and methods for treating pulmonary hypertension
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US8680124B2 (en) 2007-01-19 2014-03-25 Bayer Healthcare Llc Treatment of cancers with acquired resistance to kit inhibitors
CA2729041A1 (en) * 2008-06-25 2009-12-30 Barbara Albrecht-Kuepper Diaryl urea for treating heart failure
EP2621486A1 (en) 2010-10-01 2013-08-07 Bayer Intellectual Property GmbH Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
CA2839699A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
US8778941B2 (en) 2011-06-24 2014-07-15 Amgen Inc. TRPM8 antagonists and their use in treatments
US8586527B2 (en) * 2011-10-20 2013-11-19 Jaipal Singh Cerivastatin to treat pulmonary disorders
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CN109568319A (zh) 2013-01-10 2019-04-05 普尔莫凯恩股份有限公司 非选择性激酶抑制剂
US9925184B2 (en) 2013-10-11 2018-03-27 Pulmokine, Inc. Spray-dry formulations
US20160317542A1 (en) 2013-12-09 2016-11-03 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
US11057446B2 (en) 2015-05-14 2021-07-06 Bright Data Ltd. System and method for streaming content from multiple servers
US10231966B2 (en) 2016-10-27 2019-03-19 Pulmokine, Inc. Combination therapy for treating pulmonary hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US20020065296A1 (en) * 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
MXPA04007832A (es) * 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
CA2526617C (en) * 2003-05-20 2015-04-28 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity

Also Published As

Publication number Publication date
EP1948176A1 (en) 2008-07-30
ATE493986T1 (de) 2011-01-15
ECSP088429A (es) 2008-07-30
KR20080066030A (ko) 2008-07-15
JP2009514909A (ja) 2009-04-09
NO20082497L (no) 2008-06-03
CU23815A3 (es) 2012-06-21
JP5075832B2 (ja) 2012-11-21
SV2009002899A (es) 2009-04-28
BRPI0618524A2 (pt) 2011-09-06
MY144860A (en) 2011-11-30
IL191010A0 (en) 2009-08-03
TW200735869A (en) 2007-10-01
PL1948176T3 (pl) 2011-05-31
AU2006312713A1 (en) 2007-05-18
EP1948176B1 (en) 2011-01-05
AR057848A1 (es) 2007-12-19
CU20080082A7 (es) 2011-07-11
WO2007054215A1 (en) 2007-05-18
PT1948176E (pt) 2011-03-07
CA2628847A1 (en) 2007-05-18
DE602006019468D1 (de) 2011-02-17
UY29902A1 (es) 2007-06-29
NZ568031A (en) 2011-06-30
US20090176791A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
CY2016017I1 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK2781593T3 (da) Fremgangsmåde til behandling af methanemissioner
DK1683933T3 (da) Betjeningsgreb
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DE602006009573D1 (de) Vorspannungsschaltung
DK1943406T3 (da) Byggeelement
DK1907374T3 (da) Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater
DK1773787T3 (da) Fremgangsmåde til fremstilling af 3-phenyl(thio)uraciler og -dithiouraciler
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
DK1814555T3 (da) S-mirtazapin til behandling af hedeture
DK1789529T3 (da) Fremgangsmåde til forbedring af konserveringen af lactococcus
DK2366393T3 (da) Roflumilast til behandlingen af pulmonal hypertension
DK1856035T3 (da) Fremgangsmåde til fremstilling af beskyttelse amidiner
ITMI20050680A1 (it) Nuovi composti anti-infiammatori
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1940447T3 (da) Behandling af neurodegenrative lidelser
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin